Atlas Trials

Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation

Clinical trial NCT02571062 · COMPLETED

Trial details

NCT number
NCT02571062
Sponsor
Drugs for Neglected Diseases
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Trypanosomiasis, African
Start date
2015-03-01
Primary completion
2015-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.